Abstract:Immature teratomas are rare malignant tumors of the ovary. They are made of immature components of germ cell origin. The incidence of immature teratomas is highest in young adults aged 18 to 39. The prognosis heavily depends on the International Federation of Gynecology and Obstetrics (FIGO) staging system and is influenced by factors such as cell type, tumor grade, capsular rupture, and metastatic risk factors. Initial treatment is complete surgical resection. When indicated, platinum-based adjuvant chemotherapy with bleomycin, etoposide, and cisplatin (BEP) is the treatment of choice. Next-generation sequencing of the tumor can influence treatment in the recurrent setting. Temozolomide is an alkylating agent used to target high-grade gliomas. Bevacizumab is a targeted therapy that interferes with the process of angiogenesis by inhibiting vascular endothelial growth factor (VEGF). We report a 36-year-old female who presented with a 17.6cm x 10.5cm x 24.2cm intraabdominal mass and ascites. Upon tumor resection, she was found to have a stage IIIa, grade 2 immature teratoma of the left ovary, with glial tissue being the metastatic cell type. Disease progression continued despite treatment with BEP. She was then treated experimentally with six months of bevacizumab and temozolomide, given its rarity and targeted therapy for glial tissue. Despite monoclonal antibody therapy, the tumor progressed again and was treated with docetaxel and gemcitabine. A repeat CT of the chest, abdomen, and pelvis demonstrated scattered peritoneal implants that were increasing in size. Chromosome analysis was performed and revealed somatic mutations of MLH1, MSH2, MSH6, and PD-L1. The patient has requested a break from chemotherapy but will be treated with direct immunotherapy when she restarts. This case's importance lies in its rarity because fewer than 10 cases of immature teratomas with metastatic glial tissue are noted in the world's literature. Furthermore, this is the first reported case of this cell type being treated with immunotherapy in the world literature.

Development of immature ovarian teratoma after mature teratoma in a girl with familial ovarian teratoma: A case report

Immature ovarian teratoma in a 20-year-old woman: A case report

Immature Teratoma With Metastatic Gliosis

Ovarian Cancer Immature Teratoma Type in Pregnancy: Management and Feto-Maternal Outcomes

Management of an Incidentally Discovered Ovarian Teratoma in an Adolescent Patient

Mature Teratoma in a Supernumerary Ovary in a Child: Report of the First Case

Ovarian Cystectomy in the Treatment of Apparent Early-Stage Immature Teratoma.

Omental mature cystic teratoma mimicking a mesenteric cyst: A case report

Rare case of squamous cell carcinoma arising in a recurrent ovarian mature cystic teratoma of a young woman: A case report and review of the literature

Recurrent immature teratoma of the ovary: a case report of radical secondary cytoreduction with replacement of the aortic bifurcation.

Case report: Squamous cell carcinoma and spindle cell sarcoma (SCS) arising in a mature cystic teratoma of the ovary

Extragonadal recurrence of benign mature teratoma in the pouch of Douglas

An omental teratoma in a young girl

Dermoid cyst management and outcomes: a review of over 1000 cases at a single institution

Choroid plexus papilloma in a mature cystic teratoma of ovary: A rare case report

A curious case of ovarian cysts

Growing teratoma syndrome: diagnostic challenges and outcomes

Recurrent ovarian mixed germ cell tumor with unusual malignant transformation: a case report

Mature Mesenteric Teratoma in A Child: A Case Report

Pelvic masses after surgery for immature ovarian teratoma: A 10-year experience of Western China

Unclassified Mixed Germ Cell-Sex Cord-Stromal Tumor of the Ovary: An Unusual Case Report